Galenica Santé’s IPO swells to 100% freefloat, to price high

By Aidan Gregory
03 Apr 2017

Galenica Santé, the Swiss retail pharmacies unit of Galenica Group, has increased the size of its IPO and will price it near the top of its initial range.

Citigroup, Credit Suisse and UBS are global co-ordinators.

As a result of strong demand during bookbuilding, the base size of the all-secondary IPO will now be 42.4m shares, up from 37.5m shares. The size of the greenshoe has also been increased, from 5.6m shares to 6.36m shares.


Please take a trial or subscribe to access this content.

Contact our subscriptions team to discuss your access:

Or sign up for a trial to gain full access to the entire site for a limited period.

Free Trial

Corporate access

To discuss GlobalCapital access for your entire department or company please contact our subscriptions sales team at: or find out more online here.